Annual EBITDA
-$21.69 M
+$3.00 M+12.16%
31 December 2023
Summary:
Minerva Neurosciences annual earnings before interest, taxes, depreciation & amortization is currently -$21.69 million, with the most recent change of +$3.00 million (+12.16%) on 31 December 2023. During the last 3 years, it has fallen by -$23.81 million (-1124.68%). NERV annual EBITDA is now -1124.68% below its all-time high of $2.12 million, reached on 31 December 2020.NERV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$22.52 M
+$28.43 M+480.78%
30 September 2024
Summary:
Minerva Neurosciences quarterly earnings before interest, taxes, depreciation & amortization is currently $22.52 million, with the most recent change of +$28.43 million (+480.78%) on 30 September 2024. Over the past year, it has increased by +$28.25 million (+493.15%). NERV quarterly EBITDA is now -23.85% below its all-time high of $29.57 million, reached on 30 June 2020.NERV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$3.47 M
+$28.25 M+114.00%
30 September 2024
Summary:
Minerva Neurosciences TTM earnings before interest, taxes, depreciation & amortization is currently $3.47 million, with the most recent change of +$28.25 million (+114.00%) on 30 September 2024. Over the past year, it has increased by +$23.13 million (+117.65%). NERV TTM EBITDA is now -48.67% below its all-time high of $6.76 million, reached on 31 March 2021.NERV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.2% | +493.1% | +117.7% |
| 3 y3 years | -1124.7% | +400.1% | +111.1% |
| 5 y5 years | +56.6% | +258.1% | +106.1% |
NERV EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1124.7% | +52.1% | at high | +205.3% | at high | +107.6% |
| 5 y | 5 years | -1124.7% | +71.3% | -23.9% | +169.7% | -48.7% | +104.6% |
| alltime | all time | -1124.7% | +71.3% | -23.9% | +169.7% | -48.7% | +104.6% |
Minerva Neurosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $22.52 M(-480.8%) | $3.47 M(-114.0%) |
| June 2024 | - | -$5.91 M(-6.3%) | -$24.78 M(+7.6%) |
| Mar 2024 | - | -$6.31 M(-7.5%) | -$23.02 M(+6.1%) |
| Dec 2023 | -$21.69 M(-12.2%) | -$6.82 M(+19.1%) | -$21.69 M(+10.3%) |
| Sept 2023 | - | -$5.73 M(+37.9%) | -$19.66 M(+3.7%) |
| June 2023 | - | -$4.15 M(-16.7%) | -$18.96 M(-12.6%) |
| Mar 2023 | - | -$4.99 M(+4.0%) | -$21.69 M(-12.2%) |
| Dec 2022 | -$24.69 M(-45.5%) | -$4.79 M(-4.6%) | -$24.69 M(-40.2%) |
| Sept 2022 | - | -$5.02 M(-27.1%) | -$41.28 M(-5.7%) |
| June 2022 | - | -$6.89 M(-13.7%) | -$43.76 M(-4.5%) |
| Mar 2022 | - | -$7.99 M(-62.6%) | -$45.80 M(+1.1%) |
| Dec 2021 | -$45.28 M(-2239.0%) | -$21.38 M(+184.9%) | -$45.28 M(+45.2%) |
| Sept 2021 | - | -$7.50 M(-16.0%) | -$31.18 M(-1.8%) |
| June 2021 | - | -$8.93 M(+19.7%) | -$31.75 M(-569.6%) |
| Mar 2021 | - | -$7.47 M(+2.5%) | $6.76 M(+219.3%) |
| Dec 2020 | $2.12 M(-102.8%) | -$7.28 M(-9.8%) | $2.12 M(-109.2%) |
| Sept 2020 | - | -$8.07 M(-127.3%) | -$22.93 M(-21.2%) |
| June 2020 | - | $29.57 M(-344.2%) | -$29.10 M(-59.3%) |
| Mar 2020 | - | -$12.11 M(-62.5%) | -$71.54 M(-5.5%) |
| Dec 2019 | -$75.70 M(+51.3%) | -$32.33 M(+127.0%) | -$75.70 M(+33.8%) |
| Sept 2019 | - | -$14.24 M(+10.7%) | -$56.58 M(+4.1%) |
| June 2019 | - | -$12.86 M(-20.9%) | -$54.35 M(+0.7%) |
| Mar 2019 | - | -$16.27 M(+23.3%) | -$53.97 M(+7.9%) |
| Dec 2018 | -$50.04 M | -$13.20 M(+9.9%) | -$50.04 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$12.01 M(-3.8%) | -$45.95 M(+2.0%) |
| June 2018 | - | -$12.49 M(+1.2%) | -$45.06 M(+6.8%) |
| Mar 2018 | - | -$12.34 M(+35.5%) | -$42.18 M(+4.7%) |
| Dec 2017 | -$40.27 M(+34.3%) | -$9.11 M(-18.1%) | -$40.27 M(-0.1%) |
| Sept 2017 | - | -$11.12 M(+15.8%) | -$40.33 M(+7.9%) |
| June 2017 | - | -$9.61 M(-8.0%) | -$37.37 M(+14.3%) |
| Mar 2017 | - | -$10.44 M(+13.9%) | -$32.71 M(+9.0%) |
| Dec 2016 | -$30.00 M(+15.3%) | -$9.17 M(+12.4%) | -$30.00 M(+3.5%) |
| Sept 2016 | - | -$8.16 M(+65.2%) | -$28.99 M(+9.4%) |
| June 2016 | - | -$4.94 M(-36.1%) | -$26.49 M(-5.0%) |
| Mar 2016 | - | -$7.73 M(-5.3%) | -$27.89 M(+7.2%) |
| Dec 2015 | -$26.01 M(-52.5%) | -$8.16 M(+44.0%) | -$26.01 M(+2.8%) |
| Sept 2015 | - | -$5.66 M(-10.6%) | -$25.29 M(-45.9%) |
| June 2015 | - | -$6.33 M(+8.2%) | -$46.74 M(-19.5%) |
| Mar 2015 | - | -$5.85 M(-21.3%) | -$58.04 M(+5.9%) |
| Dec 2014 | -$54.82 M(+1610.9%) | -$7.44 M(-72.6%) | -$54.82 M(+10.9%) |
| Sept 2014 | - | -$27.11 M(+53.8%) | -$49.45 M(+116.7%) |
| June 2014 | - | -$17.64 M(+570.6%) | -$22.82 M(+310.4%) |
| Mar 2014 | - | -$2.63 M(+27.1%) | -$5.56 M(+73.7%) |
| Dec 2013 | -$3.20 M(+102.5%) | -$2.07 M(+326.1%) | -$3.20 M(+182.6%) |
| Sept 2013 | - | -$485.40 K(+29.1%) | -$1.13 M(+75.0%) |
| June 2013 | - | -$376.00 K(+38.6%) | -$647.30 K(+138.6%) |
| Mar 2013 | - | -$271.30 K | -$271.30 K |
| Dec 2012 | -$1.58 M | - | - |
FAQ
- What is Minerva Neurosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Minerva Neurosciences?
- What is Minerva Neurosciences annual EBITDA year-on-year change?
- What is Minerva Neurosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Minerva Neurosciences?
- What is Minerva Neurosciences quarterly EBITDA year-on-year change?
- What is Minerva Neurosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Minerva Neurosciences?
- What is Minerva Neurosciences TTM EBITDA year-on-year change?
What is Minerva Neurosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of NERV is -$21.69 M
What is the all time high annual EBITDA for Minerva Neurosciences?
Minerva Neurosciences all-time high annual earnings before interest, taxes, depreciation & amortization is $2.12 M
What is Minerva Neurosciences annual EBITDA year-on-year change?
Over the past year, NERV annual earnings before interest, taxes, depreciation & amortization has changed by +$3.00 M (+12.16%)
What is Minerva Neurosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of NERV is $22.52 M
What is the all time high quarterly EBITDA for Minerva Neurosciences?
Minerva Neurosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $29.57 M
What is Minerva Neurosciences quarterly EBITDA year-on-year change?
Over the past year, NERV quarterly earnings before interest, taxes, depreciation & amortization has changed by +$28.25 M (+493.15%)
What is Minerva Neurosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of NERV is $3.47 M
What is the all time high TTM EBITDA for Minerva Neurosciences?
Minerva Neurosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $6.76 M
What is Minerva Neurosciences TTM EBITDA year-on-year change?
Over the past year, NERV TTM earnings before interest, taxes, depreciation & amortization has changed by +$23.13 M (+117.65%)